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Abstract
Background: Impaired oxidative capacity of skeletal muscle mitochondria contribute to insulin resistance and type 2
diabetes (T2D). Furthermore, mRNA expression of genes involved in oxidative phosphorylation, including ATP5O, is reduced
in skeletal muscle from T2D patients. Our aims were to investigate mechanisms regulating ATP5O expression in skeletal
muscle and association with glucose metabolism, and the relationship between ATP5O single nucleotide polymorphisms
(SNPs) and risk of T2D.
Methodology/Principal Findings: ATP5O mRNA expression was analyzed in skeletal muscle from young (n= 86) and elderly
(n= 68) non-diabetic twins before and after a hyperinsulinemic euglycemic clamp. 11 SNPs from the ATP5O locus were
genotyped in the twins and a T2D case-control cohort (n= 1466). DNA methylation of the ATP5O promoter was analyzed in
twins (n= 22) using bisulfite sequencing. The mRNA level of ATP5O in skeletal muscle was reduced in elderly compared with
young twins, both during basal and insulin-stimulated conditions (p,0.0005). The degree of DNA methylation around the
transcription start of ATP5O was ,1% in both young and elderly twins and not associated with mRNA expression (p= 0.32).
The mRNA level of ATP5O in skeletal muscle was positively related to insulin-stimulated glucose uptake (regression
coefficient = 6.6; p= 0.02). Furthermore, two SNPs were associated with both ATP5O mRNA expression (rs12482697: T/T
versus T/G; p= 0.02 and rs11088262: A/A versus A/G; p= 0.004) and glucose uptake (rs11088262: A/A versus A/G; p= 0.002
and rs12482697: T/T versus T/G; p= 0.005) in the young twins. However, we could not detect any genetic association with
T2D.
Conclusions/Significance: Genetic variation and age are associated with skeletal muscle ATP5O mRNA expression and
glucose disposal rate, suggesting that combinations of genetic and non-genetic factors may cause the reduced expression
of ATP5O in T2D muscle. These findings propose a role for ATP5O, in cooperation with other OXPHOS genes, in the
regulation of in vivo glucose metabolism.
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Introduction
Insulin resistance in skeletal muscle increases with age and
during the course of type 2 diabetes mellitus (T2D). Reduced
expression of genes from the respiratory chain in the mitochondria
may cause impaired oxidative capacity in skeletal muscle which, in
turn, has been suggested to contribute to insulin resistance [1].
Indeed, a number of studies have found reduced levels of genes
involved in oxidative phosphorylation (OXPHOS) in parallel with
increased insulin resistance in skeletal muscle from patients with
T2D [2–5] and from elderly subjects [6–8]. Moreover, recent
studies from our group showed positive associations between gene
expression of the respiratory chain components NDUFB6 and
COX7A1, respectively, and insulin stimulated glucose uptake in vivo
[7,8]. Interestingly, a mRNA expression profile performed in our
laboratory showed that ATP5O was the most significantly reduced
OXPHOS gene in skeletal muscle from patients with T2D
compared with healthy control subjects (p=0.0027) [3]. However,
the cause of this reduction in ATP5O remains unknown.
Oxidative phosphorylation is a process where electrons are
passed from NADH and FADH2 along a series of carrier
molecules, protons are pumped across the inner mitochondrial
membrane to produce a proton gradient and in a final step ATP is
produced from ADP and phosphate [9]. This process occurs in the
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respiratory chain, which consists of five multiprotein complexes.
ATP5O is a nuclear encoded subunit of complex V of the
respiratory chain i.e. ATP synthase. It is located in the stalk of the
ATP synthase complex where it appears to connect the catalytic
core (F1 subunit) and the membrane proton channel (F0 subunit),
thereby influencing transmission of conformational changes and
proton conductance [10].
The aims of the present study were to investigate 1) the
mechanisms regulating ATP5O expression in skeletal muscle and 2)
if single nucleotide polymorphisms (SNPs) in ATP5O are associated
with increased risk of T2D.
Materials and Methods
Participants
Twins. Individuals were identified through The Danish Twin
Register [11] and their clinical characteristics are described in
Table 1. Selection criteria for the young and elderly twins, all non-
diabetic, have been previously described [6,11,12].
The Botnia study. This is a family based study established in
1990 aiming at the identification of T2D susceptibility genes [13].
1461 unrelated individuals from the Botnia study were included in
the present study, 751 of whom have been diagnosed with T2D
.35 years of age and 709 non-diabetic controls without first
degree relatives with T2D (Table 1). Subjects were classified into
different stages of glucose tolerance based on an oral glucose
tolerance test (OGTT). Individuals with genetically verified
Maturity Onset Diabetes of the Young (MODY) or GAD
antibody-positive patients were excluded from the study.
All studies were approved by the regional Ethics Committees
and conducted according to the Helsinki Declaration. Written
consent was obtained from all participants apart from a subset that
was enrolled in the Botnia study in the early 90’s when only verbal
informed consent was obtained.
Clinical examination
Each twin pair simultaneously underwent a 2-day clinical
examination. The subjects were instructed to restrain from
strenuous physical activity for 24 h and to fast overnight (10–
12 h) before examination. Anthropometric measures (weight,
height, BMI and waist to hip ratio) were performed as previously
described [14]. Body composition (lean body mass [LBM] and fat
mass) was determined by DEXA scanning. The subjects
underwent a 2-hour hyperinsulinemic euglycemic clamp
(40 mU m22 min21) combined with indirect calorimetry during
the basal and insulin-stimulated steady state periods as previously
described [14]. Metabolic rates (e.g. glucose disposal rate) were
calculated as previously reported and expressed as mg?(kg
LBM)21?min21 [15]. Plasma glucose and insulin concentrations
were analyzed as previously described [11].
Analysis of ATP5O mRNA levels in skeletal muscle
Muscle biopsies were obtained from the vastus lateralis muscle
from the twins during both basal and insulin-stimulated states.
Total RNA was extracted using Tri Reagent kit (Sigma-Aldrich,
St. Louise, MO, USA) and cDNA was synthesized using
Superscript II RNase H2 Reverse Transcriptase and random
hexamer primers (Invitrogen, Carlsbad, CA, USA). ATP5O
mRNA levels were quantified using TaqMan Real-Time PCR
with an ABI 7900 system (Applied Biosystems, Foster City, CA,
USA) using probe and primer pair specific for ATP5O covering
exon boundary 4–5 (Assays-on-demands, Hs00426889_m1, Ap-
plied Biosystems). For the probe/primer set a standard curve was
generated that was confirmed to increase linearly with increasing
amounts of cDNA. Each sample was run in duplicates and the
transcript quantity was normalized to the mRNA level of
cyclophilin A (4326316E, Applied Biosystems), which expression
was tested to not be affected by age.
Genotyping
Genomic DNA was extracted from blood using conventional
methods. Genotype data covering the ATP5O locus
(chr21:34230028–34187627, 20 kb upstream and 10 kb down-
stream of the ATP5O gene transcript, Fig. 1) was downloaded
from the International HapMap project (last accessed March
2008) [16] for the CEPH (Utah residents with ancestry from
northern and western Europe) population. 33 SNPs with minor
allele frequency .1% were found. Linkage disequilibrium (LD)
structure between these SNPs was analyzed using Haploview [17]
and 11 tag SNPs [18] were selected such that all alleles are
correlated at an r2.0.9 (Fig. 1). These SNPs were genotyped
using iPLEXTM assays and matrixassisted laser desorption/
ionization time-of-flight (MALDI-TOF) mass spectrometry on
the MassARRAYH system (Sequenom, San Diego, CA, USA) in
the Swegene laboratory in Malmo¨. 3 SNPs failed this method and
were analyzed by allelic discrimination using TaqManH SNP
Genotyping Assays on the ABI7900 (Applied Biosystems). Primer
sequences and additional genotyping details are available from the
authors.
DNA Methylation
Genomic DNA was isolated from muscle biopsies at the same
time as RNA using the Tri Reagent kit according to the
manufacturer’s instructions (Sigma-Aldrich). DNA bisulfite mod-
ification was accomplished on DNA from 11 young and 11 elderly
Table 1. Clinical characteristics of participants.
Young Twins Elderly Twins Botnia T2D Cases Botnia Controls
n (male/female) 110 (60/50) 86 (38/48) 751 (399/352) 709 (344/365)
n (MZ/DZ) 110 (66/44) 86 (42/44)
Age (years) 28.061.9 62.462.0* 54.569.4 53.5611.5
BMI (kg/m2) 24.163.1 26.164.4* 28.964.8 25.963.8*
Glucose uptake (mg?kg LBM21?min21) 11.763.2 9.963.3*
Fasting plasma glucose (mmol/l) 9.163.2 5.360.5*
Data are expressed as means6SD. DZ, dizygotic; MZ, monozygotic; LBM, lean body mass.
*p,0.05.
doi:10.1371/journal.pone.0004793.t001
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twins using the EZ DNA methylation kit (Zymo Research, Orange,
CA, USA). Bisulfite modified DNA was amplified with primers
designed using the program MethPrimer [19], forward primer: 59-
TTGGTTAGTAATAATGATTTTATTTTTAGA -39 and re-
verse primer 59- CTAACTCTCAAAACCACCTTTCTCT -39.
A second, semi-nested PCR was performed using the forward
primer 59- GAGGGTTTAGTTTTTATTATTGTTAAGAAT -
39 (same reverse). The resulting amplicon is 249 basepairs long and
includes 19 possible DNA methylation (CpG) sites. This region,
which is located within a CpG island, surrounds the ATP5O
transcription start site (TSS) including the beginning of exon 1 (293
to +156 in relation to TSS). The PCR products were cloned into
plasmid vectors (pCRH4-TOPOH, Invitrogen), further E. coli were
transformed and DNA from 10 colonies of each individual muscle
sample were isolated (QIAprep 8 Miniprep Kit, Qiagen Inc.,
Valencia, CA, USA). The individual clones were sequenced and the
number of methylated sites was determined using BiQ Analyzer
[20]. The sequences from all 22 individuals comprised of data from
8–10 clones. The proportion of methylation for each individual was
calculated by dividing the total number of methylated sites in all
clones by the total number of possible methylation sites.
Statistical methods
Generalized estimating equations. Conventional tests of
differences between variable (y) means are not valid for twin data
due to the strong intrapair correlation. Generalized estimating
equations (GEE) methodology (y =a+bx) was used to correct for
this dependence and provide valid standard errors for the b-
coefficients [21,22]. All observations were used for estimation of
the b-coefficient, whereas the variance of b was calculated using
each twin pair as one cluster.
Linear regression. To identify factors independently
associated with the response variable, we used backward-
elimination multivariate regression analysis with p.0.05 as the
defining criteria for exclusion of model terms. GEE methodology
was used to obtain valid tests.
Biometric modeling. Intra-class correlations, a method to
measure resemblance within twin pairs [23], were calculated for
ATP5O mRNA expression in monozygotic (MZ) and dizygotic
(DZ) twin pairs. The degree of genetic and environmental
influence of a phenotypic variable can be estimated using
biometric modeling as previously described [24]. The models
tested included the following parameters: genetic variance due to
additive genetic effects (VA) or dominant genetic effects (VD) and
environmental variance due to an individual environment not
shared with co-twin (VE) or a common environment shared among
co-twins (VC). Heritability gives the proportion of the total
variation (VT) of a trait attributable to additive genetic variation
(VA). We used the MX software package, a programme for linear
structural equation modeling, to estimate the variance components
and to compare the different models. Biometric modeling was
conducted separately in the two age groups. The fit of each model
was assessed by maximum-likelihood methods and resulted in a x2
goodness of fit index and probability value that tested the
agreement between the observed and the predicted statistics. A
small goodness of fit x2 value, a high p-value and a low AIC
(Akaike’s information criterion), which equals the x2 value minus 2
times the degree of freedom, indicates good correspondence and
were used in comparisons of each model leading to a best fitting
model.
Association between genetic variation in the ATP5O gene
and type 2 diabetes. The Genetic Power Calculator [25] was
used to calculate power for detection of association between SNPs
in the ATP5O gene region and T2D. With a minor allele frequency
of 5%, a T2D frequency of 6% and a relative risk of 1.3 at a=0.05
we have 38% power using a dominant model in the Botnia case
control study. Association of individual SNPs with T2D was
determined by logistic regression adjusted for BMI, sex and age-at-
onset (cases) or age-at-visit (controls), assuming an additive model.
Hardy Weinberg p-value, LD and haplotype block structure were
calculated using Haploview [17].
DNA methylation. Power to detect differences in DNA
methylation in our study was calculated to 53.8% (a=0.05) using
DSS research statistical power calculator (www.dssresearch.com;
Fort Worth, TX, USA).
Results
Age is associated with reduced skeletal muscle ATP5O
mRNA expression levels
The influence of age on ATP5O mRNA expression was
investigated in skeletal muscle biopsies taken from young and
elderly twins, before and during a hyperinsulinemic euglycemic
clamp. The mRNA level of ATP5O was reduced in elderly
compared with young twins, both at the basal (0.1960.007 versus
0.2860.008; p,0.0005) and insulin-stimulated (0.2160.009 versus
0.3060.01; p,0.0005) state (Fig. 2).
Heritability of skeletal muscle ATP5O mRNA expression
The degree of genetic and environmental influence on skeletal
muscle ATP5O expression was estimated in young and elderly
twins by means of intra-class correlations and biometric modeling.
In the young twins, the intra-class correlation for skeletal muscle
ATP5O expression was higher in MZ (0.77) as compared to DZ
(0.34) with a heritability of 77% (Table 2). In contrast, intra-class
correlations for skeletal muscle ATP5O expression were similar in
elderly MZ and DZ twins, and explained by a combination of
shared (41%) and unique (59%) environmental factors (Table 2).
Genetic variation is associated with ATP5O mRNA
expression in muscle of young twins
In order to evaluate the genetic factors influencing ATP5O
expression in muscle of the young twins, 11 tag SNPs (Fig. 1) were
genotyped and related to gene expression. Two polymorphisms,
rs12482697 and rs11088262, influenced the expression of ATP5O
in muscle of the young twins (rs12482697: T/T [n=65]
0.3060.010 versus T/G [n=16] 0.2560.012; p=0.02 and
rs11088262: A/A [n=70] 0.3160.012 versus A/G [n=16]
0.2560.011; p=0.004) during the clamp (Fig. 3A). These two
polymorphisms are likely to represent the same association, as they
show strong LD (r2 = 0.96). rs12482697 is located 5 kb upstream
from transcription start whereas rs11088262 is a missense
polymorphism in exon 4. However, none of the other SNPs were
Figure 1. Chromosomal position of ATP5O and location of
analyzed SNPs.
doi:10.1371/journal.pone.0004793.g001
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associated with ATP5O expression in skeletal muscle (data not
shown).
DNA methylation in the ATP5O promoter
We also tested if DNA methylation around the transcription
start of ATP5O may influence the mRNA expression in skeletal
muscle. The degree of DNA methylation was low in both young
(0.1460.07%; n=11) and elderly (0.7360.33%; n=11) twins and
there was no significant difference between the two age-groups
(p=0.16). Of note, eight young and six elderly twins showed no
methylation at all of this DNA sequence. Furthermore, we could
not observe any significant correlation between ATP5O DNA
methylation and mRNA expression (r=0.24; p=0.32).
Additional factors associated with ATP5O expression in
skeletal muscle
To examine if additional factors are associated with ATP50
expression in muscle a multivariate regression analysis was
performed including the following parameters as explanatory
variables: basal and insulin-stimulated skeletal muscle PGC-1a and
PGC-1b mRNA expression, birth weight, age, sex, BMI and
zygosity (Table S1). The final model was reached using backward
selection regression. ATP5O expression was positively related
to insulin-stimulated PGC-1a expression (regression coeffi-
cient = 0.082, p=0.0001) and inversely related to age (regression
coefficient =20.001, p=0.0001) and female sex (regression
coefficient =20.043, p=0.001).
Impact of ATP5O on in vivo glucose uptake
Oxidative capacity has been suggested to influence insulin
sensitivity. We therefore performed a regression analysis to test if
ATP5O expression in skeletal muscle is related to in vivo insulin
stimulated glucose uptake in young and elderly twins (n=155).
The following variables were included in the regression model:
ATP5O mRNA expression, zygosity, birth weight, age, sex and
BMI. Indeed, the mRNA level of ATP5O was positively related to
glucose uptake (regression coefficient = 6.6; p=0.02). Further-
more, since rs11088262 and rs12482697 influenced the expression
level of ATP5O in skeletal muscle of the young twins, we tested if
these polymorphisms also were associated with glucose uptake.
Both rs11088262 and rs12482697 showed association with insulin-
stimulated glucose uptake in the young twins (rs11088262: A/A
[n=85] 12.260.4 versus A/G [n=18] 9.860.5; p=0.002 and
rs12482697: T/T [n=79] 12.160.36 versus T/G [n=18]
9.860.6; p=0.005, Fig. 3B), but not in elderly twins.
ATP5O polymorphisms and risk of T2D
11 common variants in the ATP5O gene region were genotyped
in the Botnia case-control cohort in order to assess association to
T2D. None of the SNPs showed significant association to T2D
(Table S2).
Discussion
The key findings of the present study were that genetic variation
in the ATP5O gene region is associated with mRNA expression in
skeletal muscle and glucose uptake in young twins. Furthermore,
aging proves to have a negative effect on ATP5O mRNA
expression, which is in line with findings for other OXPHOS
genes [7,8]. Also the positive correlation between the transcrip-
tional co-activator PGC-1a and OXPHOS genes previously shown
[3] could be confirmed in our study.
ATP5O was selected for analysis in this study because it was
previously shown to be the most strongly downregulated
Table 2. Heritability of ATP5O mRNA expression in skeletal muscle from 86 young and 69 elderly twins during clamp.
Best fitting biometric models Components of variance
Model
Additive
genetic a2
Dominant
genetic d2
Common
environment c2
Unique
environment e2
Young AE 0.77 (0.55–0.88) - - 0.23 (0.12–0.45)
Elderly CE - - 0.41 (0.09–0.065) 0.59 (0.35–0.91)
Intra-class correlations Young MZ Young DZ Elderly MZ Elderly DZ
ATP5O clamp 0.77 (0.56–0.88) 0.34 (0.18–0.58) 0.50 (0.02–0.79) 0.55 (0.16–0.79)
Biometric modeling data are presented as proportion of total variance (95% CI). x2 = 0.00, p= 1.00 and Akaike’s information criteria =22.00 for the goodness of fit tests
for ATP5O expression during clamp in both young and elderly twins.
Correlation coefficients (95% CI) are presented for the intra-class correlation of ATP5O mRNA.
AE, model of additive genetic and specific environment variance; CE, model of shared and specific environment variance; DZ, dizygotic; MZ, monozygotic.
doi:10.1371/journal.pone.0004793.t002
Figure 2. Age associates with ATP5O mRNA expression in
skeletal muscle from young (n=86) and elderly (n=69) twins.
Presented values are ratios between the mRNA expression of ATP5O
and the endogenous control cyclophilin A, which was calculated for
each sample and expressed as mean6SEM. Grey bars, before; and black
bars, after a hyperinsulinemic euglycemic clamp. *p,0.05.
doi:10.1371/journal.pone.0004793.g002
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OXPHOS gene in diabetic muscle [3]. Furthermore, it encodes a
component of ATP synthase, the complex in the respiratory chain
responsible for the final step of ATP production. Including twins in
the study design gives the opportunity to estimate the relative
influence of genetic versus environmental components. Interest-
ingly, the genetic influence on ATP5O mRNA expression
estimated by both biometric modeling and intra-class correlation
was not seen in the elderly subjects, which may suggest an
accumulation of environmental factors with advancing age, which
masks the genetic component contributing to the ATP5O
expression demonstrated in young individuals.
Age is positively associated with insulin resistance and the
prevalence of T2D. Furthermore, a correlation between insulin
sensitivity and the oxidative capacity of skeletal muscle has been
reported [26]. The glucose disposal rate calculated from a
hyperinsulinemic euglycemic clamp is a reliable measure of
insulin sensitivity. In the present study, the ATP5O mRNA
expression was reduced by one third in elderly compared to
young twins, with a concomitant decrease in glucose uptake. This
is in line with other reports suggesting that age has a strong
influence on mitochondrial OXPHOS activity or OXPHOS
gene expression as well as on insulin-stimulated glucose uptake in
skeletal muscle [7,27–29]. To understand the mechanisms
responsible for this decline it would be useful to relate mRNA
expression to mitochondrial content and respiratory chain
activity in forthcoming studies.
The association between two genetic variants (rs11088262 and
rs12482697) and glucose uptake was only seen in young but not
in elderly twins. This was in agreement with the heritability
estimates, where the heritability of ATP5O mRNA expression
was estimated to 77% in the young twins, but only environmental
factors were found to influence ATP5O expression in the elderly
twins. However, we could not find any genetic association
between ATP5O SNPs and T2D in our case control cohort. T2D
is a result of several pathophysiological mechanisms, e.g.
impaired insulin secretion and insulin resistance in the liver
and peripheral tissues. Here we find in non-diabetic twins an
association between SNPs and glucose uptake, whereas the T2D
cases are characterized by a concert of different players where
perhaps an insulin secretional defect may play the lead part and
mask an association with insulin resistance. Also, this could be
due to low power as we only had 38% power to detect an
association using this design and recent genome-wide association
studies suggest that very large cohorts are needed to detect
modest association commonly seen for T2D [30]. To partially
compensate for low power we also analyzed data from a genome-
wide association scan performed by our laboratory [31] and a
T2D meta-analysis [32] for this region of the ATP5O locus
(chr21:34230028–34187627). A total number of 32 SNPs
(including imputed data) were analyzed but none showed
evidence for association with T2D.
In the promoter region of some but not all OXPHOS genes,
increased DNA methylation in elderly subjects has been reported
[7,8]. For PGC-1a, one of the master regulators of OXPHOS
genes, there was no difference in the level of DNA methylation in
skeletal muscle of young and elderly twins [7], but an increase was
found in human pancreatic islets from T2D compared to islets
from healthy organ donors [33]. With this background we wanted
to investigate the level of DNA methylation in the ATP5O
promoter region, but hardly any DNA methylation could be
detected and there was no difference between the two age groups.
In conclusion, both genetic variation and age were associated
with skeletal muscle ATP5O mRNA expression and glucose
disposal rate, suggesting that combinations of genetic and non-
genetic factors may cause the reduced expression of ATP5O in
T2D muscle. These findings propose a role for ATP5O, in
cooperation with other OXPHOS genes, in the regulation of in vivo
glucose metabolism.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0004793.s001 (0.03 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0004793.s002 (0.04 MB
DOC)
Figure 3. Two ATP5O SNPs are associated with both mRNA
expression during clamp and insulin stimulated glucose
uptake in young twins. Effects of rs12482697 respective
rs11088262 on the ATP50 mRNA levels (a) and glucose uptake (mg?kg
LBM21?min21, b). Data are expressed as mean6SEM. *p,0.05.
doi:10.1371/journal.pone.0004793.g003
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